I make a donation

EVA-G-TAVI

Usefullness of geriatric evaluation to predict mortality, functional prognosis and the quality of life after percutaneous implant of a valvular aortic prosthesis in patients aged over 75

Terminée

Colloquium "Rythme et conduction" (23 avril 2024)
Inscrivez-vous !

Bourses ACTION & PHRA 2022

La Grande Journée du Coeur (13 juin 2023)
Attention : plus que quelques places restantes !

La Grande Journée du Coeur (mardi 13 juin 2023)
Les présentations sont en ligne

Prix de Recherche Pr Jean-Philippe COLLET

objectif

Usefullness of geriatric evaluation to predict mortality, functional prognosis and the quality of life after percutaneous implant of a valvular aortic prosthesis in patients aged over 75.

date de réalisation

2015

nombre de patients

500

nombre de centres participants

14 TAVI implant centers and 13 geriatric centers in France

type de financement

Public (AOM)

Référence

NCT02424370

Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation (EVA-G-TAVI)

Study Description

Transcutaneous trans-aortic valve replacement (TAVR) is now a common procedure to treat symptomatic aortic stenosis. Although as effective and safe as surgical aortic valve replacement, it is still restricted to high surgical risk patient who are frail. The aim of the TAVI-EVA is to identify geriatric biomarkers that may help to predict survival and functional recovery after TAVR.

source clinicaltrials.gov

Autres études

ANCHOR

En cours

Demonstrate the superiority of an association of VA-ECMO and IABP with an optimal medical treatment compared with an optimal medical treatment only in cardiogenic shock AMI patients

BIO-TAVI

En cours

Correlation between the platelet reactivity, the von Willebrand factor and bleeding and thrombotic events occuring during the year following TAVI

EDUC-DAI

En cours

Impact of therapeutic education on the quality of life and the anxiety of patients with a defibrillator.